Xencor | XNCR - Ebitda





Ebitda Perubahan Tanggal
AbbVie USD 6.91B 3.22B 2026-06
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amgen USD 3.86B 1.28B 2026-03
Arrowhead Research USD -147.68M 40.33M 2026-06
AstraZeneca USD 7.46B 2.3B 2026-09
Biogen USD 450.8M 198.9M 2026-06
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Cytokinetics USD -169.32M 19.48M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
J&J USD 8.99B 721M 2026-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD -30.2M 52.15M 2026-03
Merck USD 1.42B 2.97B 2026-06
Novartis USD 8.62B 2.14B 2026-09
Pfizer USD 6.01B 18M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Xencor USD -34.63M 86.74M 2026-06